193 related articles for article (PubMed ID: 25773123)
1. Evaluation of chemotherapeutics in a three-dimensional breast cancer model.
Lovitt CJ; Shelper TB; Avery VM
J Cancer Res Clin Oncol; 2015 May; 141(5):951-9. PubMed ID: 25773123
[TBL] [Abstract][Full Text] [Related]
2. Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer.
Imamura Y; Mukohara T; Shimono Y; Funakoshi Y; Chayahara N; Toyoda M; Kiyota N; Takao S; Kono S; Nakatsura T; Minami H
Oncol Rep; 2015 Apr; 33(4):1837-43. PubMed ID: 25634491
[TBL] [Abstract][Full Text] [Related]
3. Synergism between the anticancer actions of 2-methoxyestradiol and microtubule-disrupting agents in human breast cancer.
Han GZ; Liu ZJ; Shimoi K; Zhu BT
Cancer Res; 2005 Jan; 65(2):387-93. PubMed ID: 15695378
[TBL] [Abstract][Full Text] [Related]
4. 3-D tumor model for in vitro evaluation of anticancer drugs.
Horning JL; Sahoo SK; Vijayaraghavalu S; Dimitrijevic S; Vasir JK; Jain TK; Panda AK; Labhasetwar V
Mol Pharm; 2008; 5(5):849-62. PubMed ID: 18680382
[TBL] [Abstract][Full Text] [Related]
5. Activity of anticancer agents in a three-dimensional cell culture model.
Nirmalanandhan VS; Duren A; Hendricks P; Vielhauer G; Sittampalam GS
Assay Drug Dev Technol; 2010 Oct; 8(5):581-90. PubMed ID: 20662735
[TBL] [Abstract][Full Text] [Related]
6. Breast Cancer Spheroids Reveal a Differential Cancer Stem Cell Response to Chemotherapeutic Treatment.
Reynolds DS; Tevis KM; Blessing WA; Colson YL; Zaman MH; Grinstaff MW
Sci Rep; 2017 Sep; 7(1):10382. PubMed ID: 28871147
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin resistance in breast cancer cells is mediated by extracellular matrix proteins.
Lovitt CJ; Shelper TB; Avery VM
BMC Cancer; 2018 Jan; 18(1):41. PubMed ID: 29304770
[TBL] [Abstract][Full Text] [Related]
8. Combination of standard cytotoxic agents with polyamine analogues in the treatment of breast cancer cell lines.
Hahm HA; Dunn VR; Butash KA; Deveraux WL; Woster PM; Casero RA; Davidson NE
Clin Cancer Res; 2001 Feb; 7(2):391-9. PubMed ID: 11234895
[TBL] [Abstract][Full Text] [Related]
9. Epirubicin followed by cyclophosphamide, methotrexate and 5-fluorouracil versus paclitaxel followed by epirubicin and vinorelbine in patients with high-risk operable breast cancer.
Boccardo F; Amadori D; Guglielmini P; Sismondi P; Farris A; Agostara B; Gambi A; Catalano G; Faedi M; Rubagotti A
Oncology; 2010; 78(3-4):274-81. PubMed ID: 20530973
[TBL] [Abstract][Full Text] [Related]
10. Differences in drug sensitivity between two-dimensional and three-dimensional culture systems in triple-negative breast cancer cell lines.
Muguruma M; Teraoka S; Miyahara K; Ueda A; Asaoka M; Okazaki M; Kawate T; Kuroda M; Miyagi Y; Ishikawa T
Biochem Biophys Res Commun; 2020 Dec; 533(3):268-274. PubMed ID: 32958246
[TBL] [Abstract][Full Text] [Related]
11. The relevance of using 3D cell cultures, in addition to 2D monolayer cultures, when evaluating breast cancer drug sensitivity and resistance.
Breslin S; O'Driscoll L
Oncotarget; 2016 Jul; 7(29):45745-45756. PubMed ID: 27304190
[TBL] [Abstract][Full Text] [Related]
12. Combination treatment with fulvestrant and various cytotoxic agents (doxorubicin, paclitaxel, docetaxel, vinorelbine, and 5-fluorouracil) has a synergistic effect in estrogen receptor-positive breast cancer.
Ikeda H; Taira N; Nogami T; Shien K; Okada M; Shien T; Doihara H; Miyoshi S
Cancer Sci; 2011 Nov; 102(11):2038-42. PubMed ID: 21801281
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel combinations as front-line and salvage chemotherapy regimens in advanced breast cancer.
Conte PF; Baldini E; Michelotti A; Salvadori B; Gennari A; Da Prato M; Tibaldi C; Giannessi PG; Gentile A
Semin Oncol; 1996 Dec; 23(6 Suppl 15):39-42. PubMed ID: 8996597
[TBL] [Abstract][Full Text] [Related]
14. Pilot study of vinorelbine (Navelbine) and paclitaxel (Taxol) in patients with refractory breast cancer and lung cancer.
Chang AY; Garrow GC
Semin Oncol; 1995 Apr; 22(2 Suppl 5):66-70; discussion 70-1. PubMed ID: 7740336
[TBL] [Abstract][Full Text] [Related]
15. [Overview of vinorelbine for metastatic breast cancer].
Adachi I
Nihon Rinsho; 2000 Apr; 58 Suppl():271-8. PubMed ID: 11026006
[No Abstract] [Full Text] [Related]
16. Three-dimensional chitosan scaffold-based MCF-7 cell culture for the determination of the cytotoxicity of tamoxifen.
Dhiman HK; Ray AR; Panda AK
Biomaterials; 2005 Mar; 26(9):979-86. PubMed ID: 15369686
[TBL] [Abstract][Full Text] [Related]
17. Pathological and clinical response of a primary chemotherapy regimen combining vinorelbine, epirubicin, and paclitaxel as neoadjuvant treatment in patients with operable breast cancer.
Abrial C; Van Praagh I; Delva R; Leduc B; Fleury J; Gamelin E; Sillet-Bach I; Penault-Llorca F; Amat S; Chollet P
Oncologist; 2005 Apr; 10(4):242-9. PubMed ID: 15821244
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic and Antiproliferative Effects of Preussin, a Hydroxypyrrolidine Derivative from the Marine Sponge-Associated Fungus
Malhão F; Ramos AA; Buttachon S; Dethoup T; Kijjoa A; Rocha E
Mar Drugs; 2019 Jul; 17(8):. PubMed ID: 31366127
[TBL] [Abstract][Full Text] [Related]
19. A potential target associated with both cancer and cancer stem cells: a combination therapy for eradication of breast cancer using vinorelbine stealthy liposomes plus parthenolide stealthy liposomes.
Liu Y; Lu WL; Guo J; Du J; Li T; Wu JW; Wang GL; Wang JC; Zhang X; Zhang Q
J Control Release; 2008 Jul; 129(1):18-25. PubMed ID: 18466993
[TBL] [Abstract][Full Text] [Related]
20. In vitro evaluation of curcumin effects on breast adenocarcinoma 2D and 3D cell cultures.
Abuelba H; Cotrutz CE; Stoica BA; Stoica L; Olinici D; Petreuş T
Rom J Morphol Embryol; 2015; 56(1):71-6. PubMed ID: 25826489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
